In addition, it has been found that the CXCL13 recruits B cells into prostate cancer tumors and activate the IκB kinase α-BMI1 module in cancer stem cells through the production of LT, thus promoting the progression of castration-resistant prostate cancer 188. Here, BMI1 is linked to prostate carcinoma.